Alterations in the neural growth hormone axis following hypoxic-ischemic brain injury

Molecular Brain Research

Volumn 68, Issue 1-2, 1999, Pages 88-100

  Scheepens, Arjan ^a   Sirimanne, Ernest ^a   Beilharz, Erica ^a   Breier, Bernhard H ^a   Waters, Mike J ^b   Gluckman, Peter D ^a   Williams, Chris E ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Brain; Growth hormone; Ischemia; Neurological; Stroke; Treatment

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HORMONAL REGULATION; IMMUNOHISTOCHEMISTRY; MALE; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; STROKE;

ANIMALS; APOPTOSIS; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; CEREBRAL INFARCTION; FEMALE; GROWTH HORMONE; HYPOXIA, BRAIN; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR I; MALE; NECROSIS; ORGAN SIZE; RATS; RATS, WISTAR;

ANIMALIA;

EID: 0033532365     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(99)00051-0     Document Type: Article

References (52)

1. Andronikof-Sanglade A., Fjellestad-Paulsen A., Ricard-Malivoir S., Evain-Brion D. Specific abnormalities in a visual motor psychological test in short children with abnormal growth hormone secretion. Acta Paediatrica. 86:1997;154-159.
2. Bang P., Baxter R.C., Blum W.F., Breier B.H., Clemmons D.R., Hall K., Hintz R.L., Holly J.M.P., Rosenfeld R.G., Zapf J. Valid measurements of total IGF concentrations in biological fluids: recommendations from the 3rd International Symposium on Insulin-Like Growth Factors. Endocrinology. 136:1995;816-817.
3. Banks W.A., Kastin A.J., Huang W., Jaspan J.B., Maness L.M. Leptin enters the brain by a saturable system independent of insulin. Peptides. 17:1996;305-311.
4. Bartlett W.P., Li X.S., Williams M., Benkovic S. Localization of insulin-like growth factor-1 mRNA in murine central nervous system during post-natal development. Dev. Biol. 147:1991;239-250.
5. Beck K.D., Powellbraxton L., Widmer H.R., Valverde J., Hefti F. IGF1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron. 14:1995;717-730.
6. E. Beilharz, V. Russo, G. Butler, N. Baker, B. Connor, E. Sirimanne, M. Dragunow, G. Werther, P. Gluckman, C. Williams, A. Scheepens, Coordinated and cellular-specific induction of the components of the IGF/IGFBP axis in the rat brain following hypoxic-ischemic injury, Mol. Brain. Res. (1998) in press.
7. Beilharz E.J., Bassett N.S., Sirimanne E.S., Williams C.E., Gluckman P.D. Insulin-like growth factor II is induced during wound repair following hypoxic-ischemic injury in the developing rat brain. Mol. Brain Res. 29:1995;81-91.
8. Beilharz E.J., Williams C.E., Dragunow M., Sirimanne E.S., Gluckman P.D. Mechanisms of delayed cell death following hypoxic-ischemic injury in the immature rat: evidence for apoptosis during selective neuronal loss. Mol. Brain Res. 29:1995;1-14.
9. Belchetz P.E., Ridley R.M., Baker H.F. Studies on the accessibility of prolactin and growth hormone to brain: effect of opiate agonists on hormone levels in serial, simultaneous plasma and cerebrospinal fluid samples in the rhesus monkey. Brain Res. 239:1982;310-314.
10. Blum W.F., Breier B.H. Radioimmunoassays for IGFs and IGFBPs. Growth Regulation. 4:1994;11-19.
11. Bondy C., Lee W.H. Correlation between insulin-like growth factor (IGF) binding protein-5 and IGF-I gene expression during brain development. J. Neurosci. 13:1993;5092-5104.
12. Burton K.A., Kabigting E.B., Clifton D.K., Steiner R.A. Growth hormone receptor messenger ribonucleic acid distribution in the adult male rat brain and its colocalization in hypothalamic somatostatin neurons. Endocrinology. 131:1992;958-963.
13. Cameron C.M., Kostyo J.L., Adamafio N.A., Dunbar J.C. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse. Endocrinology. 120:1987;1568-1575.
14. Cervos Navarro J., Lafuente J.V. Traumatic brain injuries: structural changes. J. Neurol. Sci. 103:1991;S3-S14. Suppl.
15. Chen L., Lund P.K., Burgess S.B., Rudisch B.E., Mcilwain D.L. Growth hormone, insulin-like growth factor I, and motoneuron size. Journal of Neurobiology. 32:1997;202-212.
16. Cittadini A., Stromer H., Katz S.E., Clark R., Moses A.C., Morgan J.P., Douglas P.S. Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation. Circulation. 93:1996;800-809.
17. Dempsey D.T., Mullen J.L., Buzby G.P. The link between nutritional status and clinical outcome: can nutritional intervention modify it? Am. J. Clin. Nutr. 47:1988;352-356. Review, 50 references.
18. Dmello S.R., Borodezt K., Soltoff S.P. Insulin-like growth factor and potassium depolarization maintain neuronal survival by distinct pathways - possible involvement of PI 3-kinase in IGF-I signaling. J. Neurosci. 17:1997;1548-1560.
19. Franke F.E., Schachenmayr W., Osborn M., Altmannsberger M. Unexpected immunoreactivities of intermediate filament antibodies in human brain and brain tumors. Am. J. Pathol. 139:1991;67-79.
20. Garofalo R.S., Rosen O.M. Insulin and insulin-like growth factor 1 (IGF-I) receptors during central nervous system development: expression of two immunologically distinct IGF-I receptor beta subunits. Molecular and Cellular Biology. 9:1989;2806-2817.
21. Guan J., Williams C.E., Gunning M., Mallard E.C., Gluckman P.D. The effects of IGF-I treatment after hypoxic-ischemic brain injury in adult rats. J. Cereb. Blood Flow Metab. 13:1993;609-616.
22. Han V.K.M. Is the central nervous system a target for growth hormone and insulin-like growth factors? Acta Paediatr. Scand. 84:1995;3-8.
23. Hasegawa O., Minami S., Sugihara H., Wakabayashi I. Developmental expression of the growth hormone receptor gene in the rat hypothalamus. Brain Res. Dev. Brain Res. 74:1993;287-290.
24. Hynes M.A., van Wyk J.J., Brooks P.J., D'Ercole A.J., Jansen M., Lund P.K. Growth hormone dependence of somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II messenger ribonucleic acids. Mol. Endocrinol. 1:1987;233-242.
25. Johansson J.O., Larson G., Andersson M., Elmgren A., Hynsjo L., Lindahl A., Isaksson O.G.P., Lindstedt S., Bengtsson B.A., Lundberg P.A. Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters. Neuroendocrinology. 61:1995;57-66.
26. Juul A., Hjortskov N., Jepsen L.T., Nielsen B., Halkjaer-Kristensen J., Vahl N., Jorgensen J.O., Christiansen J.S., Skakkebaek N.E. Growth hormone deficiency and hyperthermia during exercise: a controlled study of sixteen GH-deficient patients. J. Clin. Endocrinol. Metab. 80:1995;3335-3340.
27. Lobie P.E., Garcia Aragon J., Lincoln D.T., Barnard R., Wilcox J.N., Waters M.J. Localization and ontogeny of growth hormone receptor gene expression in the central nervous system. Dev. Brain Res. 74:1993;225-233.
28. Lynn R.B., Cao G.Y., Considine R.V., Hyde T.M., Caro J.F. Autoradiographic localization of leptin binding in the choroid plexus of ob/ob and db/db mice. Biochem. Biophys. Res. Commun. 219:1996;884-889.
29. 125I -labelled human growth hormone in adrenals and other organs of immature hypophysectomized rats Endocrinology. 88:1971;1309-1317.
30. Mustafa A., Sharma H.S., Olsson Y., Gordh T., Thoren P., Sjoquist P.O., Roos P., Adem A., Nyberg F. Vascular permeability to growth hormone in the rat central nervous system after focal spinal cord injury. Influence of a new anti-oxidant H 290/51 and age. Neurosci. Res. 23:1995;185-194.
31. Noguchi T. Retarded cerebral growth of hormone-deficient mice. Comparative Biochemistry and Physiology C: Comparative Pharmacology and Toxicology. 98:1991;239-248.
32. Noguchi T. Effects of growth hormone on cerebral development - morphological studies. Horm. Res. 45:1996;5-17.
33. Noguchi T., Sugisaki T., Takamatsu K., Tsukada Y. Factors contributing to the poor myelination in the brain of the Snell dwarf mouse. J. Neurochem. 39:1982;1693-1699.
34. Noguchi T., Sugisaki T., Watanabe M., Kohsaka S., Tsukada Y. Effects of bovine growth hormone on the retarded cerebral development induced by neonatal hydrocortisone intoxication. J. Neurochem. 38:1982;246-256.
35. Nyberg F. Aging effects on growth hormone receptor binding in the brain. Experimental Gerontology. 32:1997;521-528.
36. Ogawa E., Breier B.H., Bauer M.K., Gallaher B.W., Walton P.E., Gluckman P.D. Pretreatment with bovine growth hormone is as effective as treatment during metabolic stress to reduce catabolism in fasted lambs. Endocrinology. 137:1996;1242-1248.
37. Petito C.K. Early and late mechanisms of increased vascular permeability following experimental cerebral infarction. J. Neuropathol. Exp. Neurol. 38:1979;222-234.
38. Phelps C.J., Bartke A. Stimulatory effect of human, but not bovine, growth hormone expression on numbers of tuberoinfundibular dopaminergic neurons in transgenic mice. Endocrinology. 138:1997;2849-2855.
39. Reinhardt R.R., Bondy C.A. Insulin-like growth factors cross the blood-brain barrier. Endocrinology. 135:1994;1753-1761.
40. I.C.A.F. Robinson, R.G. Clark, Growth promotion by growth hormone and insulin-like growth factor-I in the rat, in: R.B. Heap, C.G. Prosser, G.E. Lamming (Eds.), Biotechnology in Growth Regulation, Butterworth, London, 1989, pp. 129-140.
41. Sara V.R., Lazarus L. Prenatal action of growth hormone on brain and behaviour. Nature. 250:1974;257-258.
42. Sara V.R., Lazarus L., Stuart M.C., King T. Fetal brain growth: selective action by growth hormone. Science. 186:1974;446-447.
43. Schwab S., Spranger M., Krempien S., Hacke W., Bettendorf M. Plasma insulin-like growth factor-I and IGF binding protein 3 levels in patients with acute cerebral ischemic injury. Stroke. 28:1997;1744-1748.
44. Sirimanne E.S., Blumberg R.M., Bossano D., Gunning M.I., Edwards A.D., Gluckman P.D., Williams C.E. The effect of prolonged modification of cerebral temperature on outcome following hypoxic-ischemic injury in the infant rat. Pediatr. Res. 39:1996;591-598.
45. Sirimanne E.S., Guan J., Williams C.E., Gluckman P.D. Two models for determining the mechanisms of damage and repair after hypoxic-ischemic injury in the developing rat brain. J. Neurosci. Methods. 55:1994;7-14.
46. Smith L.E., Kopchick J.J., Chen W., Knapp J., Kinose F., Daley D., Foley E., Smith R.G., Schaeffer J.M. Essential role of growth hormone in ischemia-induced retinal neovascularization. Science. 276:1997;1706-1709.
47. Sonntag W.E., Lynch C.D., Cooney P.T., Hutchins P.M. Decreases in cerebral microvasculature with age are associated with the decline in growth hormone and insulin-like growth factor. Endocrinology. 138:1997;3515-3520.
48. Symons A.L., Mackay C.A., Leong K., Hume D.A., Waters M.J., Marks S.C. Decreased growth hormone receptor expression in long bones from toothless (osteopetrotic) rats and restoration by treatment with colony-stimulating factor-1. Growth Factors. 13:1996;1.
49. Walter H., Hill D.J., Logan A. Expression of IGF-I, IGFBPs and IGF receptors (IGF-R) in the lesioned central nervous system (CNS). Growth Regulation. 4:1994;104-104. Abstract.
50. Walter H.J., Berry M., Hill D.J., Logan A. Spatial and temporal changes in the insulin-like growth factor (IGF) axis indicate autocrine/paracrine actions of IGF-I within wounds of the rat brain. Endocrinology. 138:1997;3024-3034.
51. Williams C.E., Gunn A.J., Gluckman P.D., Synek B. Delayed seizures occurring with hypoxic-ischemic encephalopathy in the fetal sheep. Pediatr. Res. 27:1990;561-565.
52. Ye P., Umayahara Y., Ritter D., Bunting T., Auman H., Rotwein P., Dercole A.J. Regulation of insulin-like growth factor I (IGF-I) gene expression in brain of transgenic mice expressing an IGF-I-luciferase fusion gene. Endocrinology. 138:1997;5466-5475.